Keyword: GlaxoSmithKline

GlaxoSmithKline will lay off nearly 100 employees at a consumer products manufacturing plant in Memphis, Tennessee.

Merck is joining the chief digital officer parade, hiring Jim Scholefield from Nike to head up IT and digital strategy—not to mention cybersecurity.

GlaxoSmithKline's new Theraflu rollout? Single-use plastic pods that fit into Keurig coffee makers, hitting shelves this month supported by an ad effort.

Another cell manufacturing facility will be built in the U.S., this by a transatlantic biotech in which GlaxoSmithKline owns a sizable share.

GlaxoSmithKline awarded its estimated $1.5 billion media planning and buying account to Publicis Media after a five-month review.

GlaxoSmithKline will keep its cephalosporin antibiotics business but reorganize it to be more efficient, cutting nearly 200 jobs in the U.K.

Tasuku Honjo wins Nobel Prize for PD-1 research; Legend fires back at CAR-T data fabrication allegation; Takeda alumni demand more on Shire buyout.

Here is some other pharma manufacturing news of note for the week.

McCann Health's new head of global GlaxoSmithKline work is a veteran agency wrangler of both pharma and consumer brands.

GlaxoSmithKline is rolling back its strict no-payments-to-doctors policy to allow some exceptions for select products and countries.